Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Model Prescribing Information: Drugs Used in Leprosy
(1998; 28 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentIntroduction
View the documentDiagnosis of leprosy
View the documentClassification of leprosy
View the documentTreatment of leprosy
View the documentTreatment of lepra reactions
View the documentTreatment of neuritis
View the documentTreatment of eye complications
View the documentManagement of nerve damage
View the documentTreatment of leprosy during pregnancy and lactation
View the documentTreatment of patient with concomitant active tuberculosis
View the documentTreatment of patients with concomitant HIV infection
Open this folder and view contentsTreatment of leprosy in special situations
Open this folder and view contentsDrug data sheets

Treatment of neuritis

Neuritis may occur during lepra reactions or may occur independent of lepra reactions. Neuritis is an acute inflammation of the nerves with nerve pain, local oedema and rapid loss of function. Neuritis may occur before leprosy is diagnosed, during leprosy treatment, or up to several years after leprosy treatment has been completed. All neuritis of less than 6 months duration should be treated with the standard 12 week regimen of oral prednisolone. The usual course of oral prednisolone treatment begins with 40-60 mg daily up to a maximum of 1 mg/kg body weight per day and normally controls the neuritis within a few days. Most neuritis can be treated successfully under field conditions with the standard 12 week oral prednisolone treatment. If patients with neuritis do not respond to corticosteroid therapy, they should be sent to the specialist centre.


to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018